The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis

Схожие документы

• Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis
  по: Nie, Run-Cong, et al.
  Опубликовано: (2021)
• The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis
  по: Nie, Run-Cong, et al.
  Опубликовано: (2020)
• The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysis
  по: Zhang, Tengfei, et al.
  Опубликовано: (2016)
• Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
  по: Yiru Long, et al.
  Опубликовано: (2022-05-01)
• The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials
  по: Xu, Yangyang, et al.
  Опубликовано: (2019)